Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENS 111 in acute unilateral vestibulopathy
MOH_2018-05-31_002425Phase 2Completed
- Sponsor
- Sensorion
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of seliforant in vestibular neuritis (3 arms), sponsored by Sensorion. Started Apr 2018; status: completed.
02
Drugs
seliforant
03
Conditions
vestibular neuritis
Beyond the preview
Go deeper on MOH_2018-05-31_002425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-05-31_002425.